GOVX GeoVax Labs is a biotechnology company developing immunotherapies and vaccines against infectious diseases and cancer.
GeoVax Labs will report Q1 2022 financial results on April 27.
Jason McCarthy from Maxim Group has a $10.00 price target for GOVX.
The stock is now $1.01.
Market Cap of only 7.23Mil.
This is a 4X upside potential short term stock in my opinion.
$GOVX looks like it has bottomed and is about to make a strong reversal to the upside.
Key levels and dates on the chart. I think we could see somewhere between 6x-12x upside from here.
Once we break the blue trendline, the next level to break is $7.91. Over $7.91 and I think we should see $30-60 by the end of the year. Break each level to the upside and should...
